Exascale Labs (XLAB) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.36, +49.61% vs the prior close of $0.91.
- Volume 15.87M shares, 70.0x its 50-day average (heavy).
- New SEC filings: 3 (Oct 15, 2026), SCHEDULE 13G (Oct 15, 2026), 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
XLAB jumps 49.6% to $1.36 on 70.0x normal volume. Closed at $1.36, +49.61% vs the prior close of $0.91. Day range $0.78β$1.45, opened at $0.86.
XLAB daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β XLAB jumps 49.6% to $1.36 on 70.0x normal volume
- Closed at $1.36, +49.61% vs the prior close of $0.91. Day range $0.78β$1.45, opened at $0.86.
- Volume was 15.87M shares, 70.0x its 50-day average of 226.68K β unusually heavy trading.
- Price is -61.5% vs its 50-day average ($3.53) and -83.8% vs its 200-day average ($8.42).
- 52-week range $0.78β$11.17; today's close sits at 6% of that range, 87.8% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 β XLAB dips 1.7% to $0.91, a 52-week low
- Closed at $0.91, -1.73% vs the prior close of $0.93. Day range $0.83β$0.99, opened at $0.99.
- Volume was 43.80K shares, 0.2x its 50-day average of 230.68K β lighter than usual.
- Price is -74.7% vs its 50-day average ($3.59) and -89.3% vs its 200-day average ($8.46).
- 52-week range $0.83β$11.17; today's close sits at 1% of that range, 91.9% below the 52-week high.
Oct 13, 2026 β XLAB slides 7.5% to $0.93, a 52-week low
- Closed at $0.93, -7.50% vs the prior close of $1.00. Day range $0.90β$1.05, opened at $0.95.
- Volume was 29.00K shares, 0.1x its 50-day average of 232.66K β lighter than usual.
- Price is -74.7% vs its 50-day average ($3.66) and -89.1% vs its 200-day average ($8.51).
- 52-week range $0.90β$11.17; today's close sits at 0% of that range, 91.7% below the 52-week high.
Oct 12, 2026 β XLAB rises 2.7% to $1.00
- Closed at $1.00, +2.67% vs the prior close of $0.97. Day range $0.95β$1.05, opened at $1.03.
- Volume was 62.10K shares, 0.3x its 50-day average of 233.01K β lighter than usual.
- Price is -73.2% vs its 50-day average ($3.74) and -88.3% vs its 200-day average ($8.55).
- 52-week range $0.94β$11.17; today's close sits at 1% of that range, 91.0% below the 52-week high.
Oct 9, 2026 β XLAB slides 4.5% to $0.97, a 52-week low, 12 down days in a row
- Closed at $0.97, -4.51% vs the prior close of $1.02. Day range $0.96β$1.02, opened at $0.98.
- Volume was 19.50K shares, 0.1x its 50-day average of 236.69K β lighter than usual.
- Price is -74.5% vs its 50-day average ($3.82) and -88.7% vs its 200-day average ($8.60).
- 52-week range $0.94β$11.17; today's close sits at 0% of that range, 91.3% below the 52-week high.
- That makes 12 straight losses.
Oct 8, 2026 β XLAB ends flat (+0.0%) to $1.02, 11 down days in a row
- Closed at $1.02, +0.00% vs the prior close of $1.02. Day range $0.96β$1.05, opened at $0.99.
- Volume was 34.40K shares, 0.1x its 50-day average of 238.37K β lighter than usual.
- Price is -73.8% vs its 50-day average ($3.90) and -88.2% vs its 200-day average ($8.64).
- 52-week range $0.94β$11.17; today's close sits at 1% of that range, 90.9% below the 52-week high.
- That makes 11 straight losses.
Oct 7, 2026 β XLAB slides 5.6% to $1.02, a 52-week low, 10 down days in a row
- Closed at $1.02, -5.56% vs the prior close of $1.08. Day range $0.94β$1.13, opened at $1.07.
- Volume was 155.80K shares, 0.6x its 50-day average of 241.02K.
- Price is -74.2% vs its 50-day average ($3.96) and -88.3% vs its 200-day average ($8.69).
- 52-week range $0.94β$11.17; today's close sits at 1% of that range, 90.9% below the 52-week high.
- That makes 10 straight losses.
Oct 6, 2026 β XLAB slides 22.0% to $1.08, a 52-week low, 9 down days in a row
- Closed at $1.08, -22.02% vs the prior close of $1.38. Day range $1.02β$1.37, opened at $1.36.
- Volume was 240.00K shares, 1.0x its 50-day average of 242.99K.
- Price is -73.3% vs its 50-day average ($4.05) and -87.6% vs its 200-day average ($8.73).
- 52-week range $1.02β$11.17; today's close sits at 1% of that range, 90.3% below the 52-week high.
- That makes 9 straight losses.
Oct 5, 2026 β XLAB dips 1.1% to $1.38, a 52-week low, 8 down days in a row
- Closed at $1.38, -1.07% vs the prior close of $1.40. Day range $1.22β$1.54, opened at $1.39.
- Volume was 116.00K shares, 0.4x its 50-day average of 268.96K β lighter than usual.
- Price is -66.9% vs its 50-day average ($4.18) and -84.2% vs its 200-day average ($8.78).
- 52-week range $1.22β$11.17; today's close sits at 2% of that range, 87.6% below the 52-week high.
- That makes 8 straight losses.
Oct 2, 2026 β XLAB slides 4.8% to $1.40, a 52-week low, 7 down days in a row
- Closed at $1.40, -4.76% vs the prior close of $1.47. Day range $1.31β$1.54, opened at $1.52.
- Volume was 119.20K shares, 0.4x its 50-day average of 302.93K β lighter than usual.
- Price is -67.9% vs its 50-day average ($4.36) and -84.1% vs its 200-day average ($8.82).
- 52-week range $1.31β$11.17; today's close sits at 1% of that range, 87.5% below the 52-week high.
- That makes 7 straight losses.
XLAB latest news & SEC filings
Every SEC filing by or about XLAB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Oct 15, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
Oct 6, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 6, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 6, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 6, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 5, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Sep 30, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Sep 28, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 28, 2026 Β· Form 8-K/A β Current report (amended)
Amended current report
- Item 2.01 β Completed an acquisition or sale of assets.
Sep 28, 2026 Β· Form 10-K β Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $14.82M (prior year $7.02M) (+111.3% vs Jun 30, 2025)
- Net income: -$12.16M (prior year -$7.66M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$8108.26 (prior year -$5106.44) (loss widened vs Jun 30, 2025)
Sep 8, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Sep 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 1.02 β Ended a material agreement.
- Item 2.01 β Completed an acquisition or sale of assets.
- Item 3.01 β Stock exchange listing notice or transfer of listing.
- Item 3.03 β Change to shareholder rights.
- Item 4.01 β Changed its outside auditor.
- Item 5.01 β Change in control of the company.
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
- Item 5.06
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade XLAB
- Last results release: Sep 28, 2026 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 8.23% (largest 49.6%). That is a volatile stock.
- Liquidity: about 872.11K shares (β$1.19M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.36 vs a range of $0.78β$11.17 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 15, 2026; 8-K Sep 30, 2026; 8-K Sep 28, 2026.
- Listing: Nasdaq Β· industry: Services-Prepackaged Software.
XLAB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.86 | 1.45 | 0.78 | 1.36 | 15.87M |
| Oct 14, 2026 | 0.99 | 0.99 | 0.83 | 0.91 | 43.80K |
| Oct 13, 2026 | 0.95 | 1.05 | 0.90 | 0.93 | 29.00K |
| Oct 12, 2026 | 1.03 | 1.05 | 0.95 | 1.00 | 62.10K |
| Oct 9, 2026 | 0.98 | 1.02 | 0.96 | 0.97 | 19.50K |
| Oct 8, 2026 | 0.99 | 1.05 | 0.96 | 1.02 | 34.40K |
| Oct 7, 2026 | 1.07 | 1.13 | 0.94 | 1.02 | 155.80K |
| Oct 6, 2026 | 1.36 | 1.37 | 1.02 | 1.08 | 240.00K |
| Oct 5, 2026 | 1.39 | 1.54 | 1.22 | 1.38 | 116.00K |
| Oct 2, 2026 | 1.52 | 1.54 | 1.31 | 1.40 | 119.20K |
| Oct 1, 2026 | 1.85 | 1.96 | 1.47 | 1.47 | 191.30K |
| Sep 30, 2026 | 2.07 | 2.07 | 1.76 | 1.85 | 78.10K |
| Sep 29, 2026 | 2.22 | 2.31 | 1.84 | 2.07 | 88.90K |
| Sep 28, 2026 | 2.45 | 2.50 | 2.01 | 2.40 | 126.10K |
| Sep 25, 2026 | 2.58 | 2.74 | 2.35 | 2.43 | 28.80K |
| Sep 24, 2026 | 2.86 | 3.07 | 2.45 | 2.58 | 94.70K |
| Sep 23, 2026 | 2.82 | 3.00 | 2.67 | 2.75 | 12.90K |
| Sep 22, 2026 | 2.85 | 2.91 | 2.55 | 2.74 | 77.70K |
| Sep 21, 2026 | 2.94 | 3.00 | 2.78 | 2.80 | 15.80K |
| Sep 18, 2026 | 2.97 | 3.01 | 2.77 | 2.93 | 35.50K |
About Exascale Labs
Exascale Labs (XLAB) is listed on the Nasdaq and classified by the SEC under βServices-Prepackaged Softwareβ. Its business address is in HOUSTON, TX. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 2109869.
XLAB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David Edward Card | Director | Sep 8, 2026 |
| Wenying Jia | Director | Sep 8, 2026 |
| Shachar Kariv | Director | Sep 8, 2026 |
| Hoan Soo Lee | Chief Executive Officer | Sep 8, 2026 |
| Jaeyoung Shin | Director | Sep 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hoan Soo Lee | Chief Executive Officer | Sep 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
XLAB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $14.82M | $-12.16M | -8,108.26 | $-2.75M |
| Jun 30, 2025 | $7.02M | $-7.66M | -5,106.44 | $-1.01M |
Latest balance sheet: total assets $6.73M, total liabilities $31.89M, cash $2.69M (as of Jun 30, 2026).
XLAB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 28, 2026 | 8-K Item 2.02 (results) | $2.40 |
Related stocks Β· Services-Prepackaged Software
Microsoft (MSFT)Palantir Technologies (PLTR)Oracle (ORCL)CoreWeave (CRWV)CrowdStrike (CRWD)Salesforce (CRM)Shopify (SHOP)ServiceNow (NOW)Snowflake (SNOW)Twilio (TWLO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on XLAB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.